Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes. - Wikidata - awgldk - TriplyDB

Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.

Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.

http://www.wikidata.org/entity/Q30418861

about

Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials Alternative Donor Transplantation for Acute Myeloid Leukemia Which donor or graft source should you choose for the strongest GVL? Is there really any difference Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes.Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis.Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies Umbilical cord blood transplantation: the first 25 years and beyond.Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study.Concise review: umbilical cord blood transplantation: past, present, and future Rapid, scalable and highly automated HLA genotyping using next-generation sequencing: a transition from research to diagnostics Donor-recipient allele-level HLA matching of unrelated cord blood units reveals high degrees of mismatch and alters graft selection.Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen.Better allele-level matching improves transplant-related mortality after double cord blood transplantation.Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type.High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation.Immune recovery after allogeneic hematopoietic stem cell transplantation: is it time to revisit how patients are monitored?Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood.Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France.GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available?Hematopoietic stem cell transplantation for acute myeloid leukemia: to whom, when, and how.Cord Blood Transplantation: Can We Make it Better?Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Umbilical cord blood donation: public or private?Cord blood transplant for acute myeloid leukaemia.Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.Impact of the source of hematopoietic stem cell in unrelated transplants: comparison between 10/10, 9/10-HLA matched donors and cord blood.Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning Effect of graft source on mismatched unrelated donor hemopoietic stem cell transplantation after reduced intensity conditioning.Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of E Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation.A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies.

P2860

Q26772216-55EE477B-C3E3-4AF9-9272-E8106F33A517 Q26799456-43AD7DC2-1847-4210-A6B6-1D1712515B12 Q26823536-00F2DC6E-BA86-43E3-82D8-A65925BB9B5D Q28080943-89AAB0F0-1026-46E1-B0F1-81A6625FD5F8 Q30252339-6ECD7113-5E1C-444A-9067-09878E973DF0 Q30252975-AF404193-E9EA-4078-9E9D-956629C00290 Q33810316-9E9B35D7-CC1C-439E-B182-ADA370E93729 Q33859061-ABB74287-1299-41F1-B196-AC1F1CE9C967 Q33897804-5268C60D-0A9B-44A2-97C9-92742FDD4C9C Q34175568-C13E489B-EC0F-4A3F-B366-35341735E1DE Q34344669-28E07228-2D96-4893-AC45-32D39B2A75B0 Q34463602-09DD7304-EB30-4B86-A15F-9080BC8AC3D7 Q34601968-86A404B2-6BC1-47A6-BF26-E473B3122D84 Q34655295-C0268BC7-0109-42F0-9682-9A91CB5CD7AA Q35200303-691E24CA-6ACD-45C7-A981-8A52F18313F7 Q35976578-48333BE6-805A-4AFA-A871-6607F4741624 Q36036346-35BF9F66-6A34-4B43-8BBA-3733E8B63E27 Q36115699-BB785338-DF25-4370-B309-931FAFCD8D7D Q36530726-16EB911A-2889-4CF8-B6B8-6102E9C9E6C8 Q36622322-C9B0A917-9E6D-4A99-85B9-97FDCB16A7B1 Q36702752-AD10E043-DE60-457D-98D1-43B8E0AD693A Q36905573-BF601DFD-991D-4750-92F0-1998FDD1BF7A Q37211141-F0BE8687-9E1F-438F-91D8-682599BAF77A Q37216236-2A9354CB-B27E-4DCE-B7A6-F1030F0313EC Q37552077-EC8C96F7-904B-4A79-B3E5-4EC553C5F152 Q37618923-74FA0887-443E-492E-B5B8-22E9C9A3E8F4 Q37675185-D472A3B5-6F8A-4E34-A164-938E788C149E Q38087853-EB15CF92-1F43-4130-A6FD-45E7BFFEA667 Q38130168-B164287F-FAC9-487D-BBE9-2887AA7F72D0 Q38142167-308A5206-5107-4EAA-9E6B-31007BF509A3 Q38387292-543D302D-29ED-4CF8-92B5-6E043C4B9BDF Q38510475-986CB6AB-63D8-419E-B673-53C653D3F1C3 Q38696346-0823C8F4-ABBF-41CD-B072-037DE074882D Q38747929-6E26321F-ECF8-453D-8DF6-1DBBFD15CE43 Q40763299-71DA3169-589E-44F8-A251-CAC06DE8CAC9 Q40791419-F37D39CD-DB18-4DD9-B484-72B6619E4DAE Q46621133-58BB1853-C796-41F5-8EEE-F880D82BBABF Q46788345-14E19DCD-DE8C-4247-A440-270CB645F357 Q47570389-CBB098C6-3E4E-49F7-8532-AFA36D91A2BF Q48134193-A75A53F1-31F1-43F2-BB4C-79FD3517113D

P2860

Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.

http://www.wikidata.org/entity/Q30418861

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Reduced-intensity conditioning ...... donor stem cells on outcomes.

@ast

Reduced-intensity conditioning ...... donor stem cells on outcomes.

@en

type

label

Reduced-intensity conditioning ...... donor stem cells on outcomes.

@ast

Reduced-intensity conditioning ...... donor stem cells on outcomes.

@en

prefLabel

Reduced-intensity conditioning ...... donor stem cells on outcomes.

@ast

Reduced-intensity conditioning ...... donor stem cells on outcomes.

@en

P1433

Q30418861-4168F7C0-124B-41B7-938D-E5E0A3BF9335

P1476

Q30418861-C090A613-441F-4F10-99F2-6F1A6F2BE457

P2093

Q30418861-28F56C3D-519B-46BE-B5B3-8FCD3AB9992D

Q30418861-2C1E00C4-E0F9-4244-9C82-8A52B2FBC65B

Q30418861-307D9A33-DD5D-41CA-A03A-6519082E29D4

Q30418861-3BAE7F94-A4E7-4F49-8C7C-240C3497EFBE

Q30418861-63D00294-7924-4B2E-9D51-BA8B46DA80C6

Q30418861-7D5CE1F7-F495-44D9-9DA9-0C4D44CDB14C

Q30418861-8FB7A948-B1A9-41AC-99F8-48DEBBCBD71D

Q30418861-B25AA97C-0B73-4ADB-8BBA-02F1F2EBBCFA

Q30418861-C4074526-1540-4BA3-BC33-CB8C55FA3FE9

Q30418861-CCF24104-03FB-4C99-9320-983689124CC2

P2860

Q30418861-0622D53A-6038-4300-B04D-1839123451CD

Q30418861-073830EC-653B-4593-B6A8-15709CF66CAE

Q30418861-2829807D-7C73-4907-A2E0-A0320563702F

Q30418861-297CBB14-7890-4A65-B484-C6320D7121BA

Q30418861-3548CCB8-BA2F-45D2-AC06-3C3E9046D23E

Q30418861-527B2F05-0EDD-44EB-8325-DE0E2C664617

Q30418861-5A4627C5-A9FD-439A-93E3-DA6CC48C5E27

Q30418861-61050FB1-89F8-48D3-8430-A10F9F99E409

Q30418861-6A783133-4996-4C0F-99FD-C74F83851C4F

Q30418861-6E9B2CB1-04D4-4066-A336-488CC9A87273

P304

Q30418861-8603E2FE-7D92-4B30-97AF-6E8898F34C15

P31

Q30418861-0DEE7841-465C-4083-BB41-C96F9B05FEEB

P356

Q30418861-23CD6ABE-5D53-4C1A-BB14-1B9128A9FCED

P407

Q30418861-75AC0C1D-594B-4F86-A3F9-3CE581054D72

P433

Q30418861-C1C0052F-5F45-4032-B734-660B9C2AE837

P478

Q30418861-A9936E2D-8B4F-4BC1-BF96-A0B525AE85FB

P50

Q30418861-5D821FA9-0191-4D65-A599-D9DC88A9474B

P577

Q30418861-9E465E9B-AD8F-4103-877D-2EEC33F06DD6

P5875

Q30418861-D4CF1F2F-9A35-4FF6-B3EB-E777ED8970FA

P698

Q30418861-4FC99D38-5748-43A4-95DB-E3CEFEFFD9B3

P921

Q30418861-983A9206-5521-47E7-98A2-0ED12CB940BE

P932

Q30418861-9DAF6696-43EC-434A-B0D5-B1A04068AD1E

P356

BLOOD-2011-12-400630

P1433

P1476

Reduced-intensity conditioning ...... donor stem cells on outcomes.

@en

P2093

Anne Woolfrey

http://www.w3.org/2001/XMLSchema#string

Claudio G Brunstein

http://www.w3.org/2001/XMLSchema#string

Corey Cutler

http://www.w3.org/2001/XMLSchema#string

Daniel J Weisdorf

http://www.w3.org/2001/XMLSchema#string

Fangyu Kan

http://www.w3.org/2001/XMLSchema#string

John E Wagner

http://www.w3.org/2001/XMLSchema#string

Karen K Ballen

http://www.w3.org/2001/XMLSchema#string

Kwang Woo Ahn

http://www.w3.org/2001/XMLSchema#string

Mary Eapen

http://www.w3.org/2001/XMLSchema#string

Mary J Laughlin

http://www.w3.org/2001/XMLSchema#string

P2860

Pathophysiology and treatment of graft-versus-host disease.

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.

Double unrelated reduced-intensity umbilical cord blood transplantation in adults.

Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis.

Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.

P304

5591-5598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2011-12-400630

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Frederick R. Appelbaum

P577

2012-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223977426

http://www.w3.org/2001/XMLSchema#string

P698

22496153

http://www.w3.org/2001/XMLSchema#string

P921

P932

3369691

http://www.w3.org/2001/XMLSchema#string